The Path Less Traveled

By Bob Grant The Path Less Traveled A freshly demonstrated theory on how peptides enter cells sparks ongoing debate. The uptake of fluorescein-labeled peptides into cells via endocytosis at 5 microM peptide (top) and independent of endocytosis at 20 microM peptide (bottom) Courtesy of Roland Brock Describing how peptides and proteins traverse cell membranes is huge in the field of cell biology. Peptides, short chains of amino acids,

Written byBob Grant
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Describing how peptides and proteins traverse cell membranes is huge in the field of cell biology. Peptides, short chains of amino acids, could one day be used as molecular ferries transporting therapeutic genes or proteins across lipid bilayers and directly into the cytosol, where many crucial biochemical pathways start. But the journey from outside a cell to the cytoplasm is no small feat for bulky peptides—researchers have been trying to map the various routes for decades.

Since the early 1990s, researchers studying how cell-penetrating peptides, which include some transcription factors and parts of viruses, gain access to the inside of cells have focused on different modes of endocytosis—where cells encapsulate extracellular material in membrane-bound vesicles and import them. Several flavors of endocytosis exist, from macropinocytosis, where cells gulp in large amounts of extracellular fluid containing macromolecules in solution, to uptake mediated by membrane proteins or lipids.

In 2007, a paper ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies